NF1 and malignant peripheral nerve sheath tumor: Most NF1 patients develop MPNST during their 3rd to 4th decades, even if malignant transformation can also occur in childhood [notably, children/adults harbouring NF1 gene deletions (i.e., the so-called “NF1 microdeletion syndrome” (Table 2), are at higher risk of malignant transformation].